"Palomar Medical Technologies Inc. (NASDAQ: PMTI) is seeing shares surge to new heights not seen in 18-months. The company is the first to receive FDA approval for over-the-counter clearance for a new, patented home use laser device that for the treatment of periorbital wrinkles (for eyes, like crows feet). The beauty of this, no pun intended, is that it is part of a Johnson & Johnson (NYSE: JNJ) partnership and that may lead to much greater use. This one will not exactly kill the entire Botox market for Allergan, Inc. (NYSE: AGN), but even for one such possible replacement the idea of a home-use laser has to be a bit more enticing than getting stuck with a needle full of Botulinum toxins."
Palomar's entry into the home use cosmetic device market simply expands the 5 year growth of such technologies. Palomar's home unit for skin rejuvenation joins other home use devices such as Tanda and Zeno for acne and the Tria and Silk'n for hair removal. What is clear is that home devices will expand the continued interest in non-surgical skin health. At the same time, it must be emphasized that such low powered technologies will never be as effective as those that are used in a physician's office.
Dr. David J. Goldberg
Sanctuary Medical Aesthetic Center, Boca Raton
Skin Laser Surgery Specialists of NY/NJ
Dr. Jason Pozner
Sanctuary Medical Aesthetic Center, Boca Raton
Sanctuary Plastic Surgery, Boca Raton
Your site very useful.
ReplyDeleteWhen I read the article and see a variety, it makes me happy.
Permission to offer my website,
A site about botox injections cost
thank a lot your information
and thank you very much for I had the opportunity to publish my work. :)